Gene-activated hyaluronic acid-based cryogels for cartilage tissue engineering
Journal of Controlled Release · 2023
DOI: 10.1016/j.jconrel.2023.09.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Natalia Carballo-Pedrares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gene & Cell Therapy Unit (G-CEL), Centro Interdisciplinar de Química e Bioloxía - CICA, Universidade da Coruña, As Carballeiras, s/n. Campus de Elviñ…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Tissue Engineering, SOX9 Transcription Factor, Cryogels. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Articular cartilage injuries are very frequent lesions that if left untreated may degenerate into osteoarthritis. Gene transfer to mesenchymal stem cells (MSCs) provides a powerful approach to treat these lesions by promoting their chondrogenic differentiation into the appropriate cartilage phenotype. Non-viral vectors constitute the safest gene transfer tools, as they avoid important concerns of viral systems including immunogenicity and insertional mutagenesis. However, non-viral gene transfer usually led to lower transfection efficiencies when compared with their viral counterparts. Biomaterial-guided gene delivery has emerged as a promising alternative to increase non-viral gene transfer efficiency by achieving sustained delivery of the candidate gene into cellular microenvironment. In the present study, we designed hyaluronic acid-based gene-activated cryogels (HACGs) encapsulating a novel formulation of non-viral vectors based on niosomes (P80PX) to promote MSCs in situ transfection. The developed HACG P80PX systems showed suitable physicochemical properties to promote MSCs in situ transfection with very low cytotoxicity. Incorporation of a plasmid encoding for the transcription factor SOX9 (psox9) into HACG P80PX systems led to an effective MSCs chondrogenic differentiation with reduced expression of fibrocartilage and hypertrophic markers. The capacity of the developed systems to restore cartilage extracellular matrix was further confirmed in an ex vivo model of chondral defect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene & Cell Therapy Unit (G-CEL), Centro Interdisciplinar de Química e Bioloxía - CICA, Universidade da Coruña, As Carballeiras, s/n. Campus de Elviña, 15071 A Coruña, Spain.
- Gene & Cell Therapy Unit (G-CEL), Centro Interdisciplinar de Química e Bioloxía - CICA, Universidade da Coruña, As Carballeiras, s/n. Campus de Elviña, 15071 A Coruña, Spain; Department of Biology, Facultade de Ciencias…
- Department of Biology, Facultade de Ciencias, Universidade da Coruña, Coruña, Spain.
Zitieren
APA
Carballo-Pedrares, N., López-Seijas, J., Miranda-Balbuena, D., Lamas, I., Yáñez, J., & Rey-Rico, A. (2023). Gene-activated hyaluronic acid-based cryogels for cartilage tissue engineering. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.09.008
Vancouver
Carballo-Pedrares N, López-Seijas J, Miranda-Balbuena D, Lamas I, Yáñez J, Rey-Rico A. Gene-activated hyaluronic acid-based cryogels for cartilage tissue engineering. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2023.09.008
BibTeX
@article{CarballoPedrares2023,
author = {Carballo-Pedrares, Natalia and López-Seijas, Junquera and Miranda-Balbuena, Diego and Lamas, Ibán and Yáñez, Julián and Rey-Rico, Ana},
title = {Gene-activated hyaluronic acid-based cryogels for cartilage tissue engineering},
journal = {Journal of Controlled Release},
year = {2023},
doi = {10.1016/j.jconrel.2023.09.008}
}
EUVIMED